Notice: This company has been marked as potentially delisted and may not be actively trading. Meridian Bioscience (VIVO) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Will iQOO 13 launch at same price as iQOO 12? New leak provides major hintOctober 25, 2024 | msn.comMeridian Growth Legacy MERDXOctober 17, 2024 | morningstar.comVivo V40 vs Realme GT 6T: How the two mid-range smartphones compareAugust 11, 2024 | msn.comMeridian Bioscience Leads the Way with Innovative Sustainable Solutions for in vitro Diagnostic ManufacturersJuly 23, 2024 | finance.yahoo.comBiomerica, Inc. (BMRA)May 11, 2024 | finance.yahoo.comMeridian Meadows Transitional CareFebruary 8, 2024 | health.usnews.comMeridian Bioscience Earns EcoVadis Bronze Medal in Recognition of Its Dedication to SustainabilityNovember 28, 2023 | benzinga.comMeridian Bioscience Continues Expansion of H. pylori Diagnostic Testing Solutions with FDA Clearance of Premier HpSA FlexJuly 25, 2023 | finance.yahoo.comRapid Testing Kits Market Size Opportunities, Top Countries Data, Future Trends and Share Forecast 2028May 17, 2023 | marketwatch.comRapid Testing Kits Market Size with Growth Opportunities, Top Countries Data, Future Trends and Share with Revenue Forecast 2028April 27, 2023 | marketwatch.comMeridian Bioscience Stock To Go Ex-dividend Tomorrow (VIVO)April 19, 2023 | thestreet.comMeridian Bioscience Announces FDA Clearance for Innovative Curian® Shiga Toxin AssayApril 19, 2023 | markets.businessinsider.comFormer executives at Meridian Bioscience subsidiary facing federal chargesApril 6, 2023 | bizjournals.comMeridian Bioscience Comments on DOJ Announcement Regarding Former Executives of Magellan DiagnosticsApril 5, 2023 | markets.businessinsider.comMeridian Bioscience Stock Hits New 52-Week Low (VIVO)March 30, 2023 | thestreet.comMeridian Bioscience Stock Hits New 52-Week High (VIVO)March 26, 2023 | thestreet.comPhoenix Union Bioscience High SchoolMarch 23, 2023 | usnews.comGlobal "Diagnostics PCR Market" 2023: On-going Trends and Growth Insights by 2027March 20, 2023 | marketwatch.comMeridian Bioscience, Inc.: SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian BioscienceFebruary 1, 2023 | finanznachrichten.deMeridian Bioscience finalizes $1.53B sale to South Korean-based firmsFebruary 1, 2023 | finance.yahoo.comSD Biosensor and SJL Partners Complete Transaction to Acquire Meridian BioscienceJanuary 31, 2023 | finance.yahoo.comTrading was temporarily halted for "VIVO" at 07:01 PM with a stated reason of "News pending."January 31, 2023 | marketbeat.comComerica Bank Reduces Stock Position in Meridian Bioscience, Inc. (NASDAQ:VIVO)Comerica Bank trimmed its holdings in shares of Meridian Bioscience, Inc. (NASDAQ:VIVO - Get Rating) by 10.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 33,486 shares of the company's stock after selling 3,722 shares dJanuary 25, 2023 | marketbeat.comRoyce & Associates LP Sells 1,508,085 Shares of Meridian Bioscience, Inc. (NASDAQ:VIVO)Royce & Associates LP lowered its stake in Meridian Bioscience, Inc. (NASDAQ:VIVO - Get Rating) by 89.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 169,169 shares of the company's stJanuary 24, 2023 | marketbeat.comBrinker Capital Investments LLC Trims Stake in Meridian Bioscience, Inc. (NASDAQ:VIVO)Brinker Capital Investments LLC reduced its holdings in shares of Meridian Bioscience, Inc. (NASDAQ:VIVO - Get Rating) by 12.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 32,225 shares of the company's stoJanuary 23, 2023 | marketbeat.comSG Americas Securities LLC Purchases 21,382 Shares of Meridian Bioscience, Inc. (NASDAQ:VIVO)SG Americas Securities LLC raised its stake in Meridian Bioscience, Inc. (NASDAQ:VIVO - Get Rating) by 98.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 43,010 shares of the company's stock after buying anJanuary 17, 2023 | marketbeat.comStrs Ohio Buys 10,100 Shares of Meridian Bioscience, Inc. (NASDAQ:VIVO)Strs Ohio lifted its stake in shares of Meridian Bioscience, Inc. (NASDAQ:VIVO - Get Rating) by 61.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 26,600 shares of the company's stock afJanuary 16, 2023 | marketbeat.comMeridian Bioscience's Return On Capital Employed OverviewDecember 29, 2022 | benzinga.comMeridian Biosciences: Why I Moved On But May Go Back InDecember 13, 2022 | seekingalpha.comMeridian Bioscience Announces Anticipated Closing Date of the Pending MergerDecember 12, 2022 | finance.yahoo.comMeridian Bioscience sets closing date for $1.53 billion dealDecember 12, 2022 | finance.yahoo.comMeridian Bioscience (NASDAQ:VIVO) Stock Rating Reaffirmed by William BlairNovember 29, 2022 | marketbeat.comMeridian Bioscience Non-GAAP EPS of $0.21, revenue of $65.67MNovember 22, 2022 | seekingalpha.comMeridian Bioscience (VIVO) Q4 Earnings Surpass EstimatesNovember 22, 2022 | finance.yahoo.comMeridian Bioscience (VIVO) to Release Quarterly Earnings on MondayMeridian Bioscience (NASDAQ:VIVO) will be releasing earnings on Monday, November 21, Yahoo Finance reports.November 20, 2022 | marketbeat.comMeridian Bioscience (NASDAQ:VIVO) Downgraded by StockNews.com to "Hold"StockNews.com cut Meridian Bioscience from a "buy" rating to a "hold" rating in a research note on Saturday.November 19, 2022 | marketbeat.comBellRing Brands (BRBR) Beats Q4 Earnings EstimatesNovember 17, 2022 | finance.yahoo.comMeridian Bioscience, Inc. (NASDAQ:VIVO) Sees Large Drop in Short InterestOctober 15, 2022 | marketbeat.comMeridian Bioscience, Inc. (VIVO)October 15, 2022 | uk.finance.yahoo.comMeridian Bioscience (NASDAQ:VIVO) Now Covered by StockNews.comOctober 12, 2022 | marketbeat.comVivo X Fold Plus launched: Check price, specifications and other detailsSeptember 28, 2022 | msn.comVIVO Meridian Bioscience, Inc.September 20, 2022 | seekingalpha.comINVESTIGATION ALERT: Halper Sadeh LLC Investigates VIVO, OCSL, AVLRSeptember 15, 2022 | apnews.comSHAREHOLDER UPDATE: Halper Sadeh LLC Investigates VIVO, SAVE, AAWW, MNRLSeptember 14, 2022 | markets.businessinsider.comHere's when Meridian Bioscience investors will vote on firm's $1.53B acquisitionSeptember 12, 2022 | finance.yahoo.comMeridian Bioscience IncSeptember 3, 2022 | reuters.comSHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates RFP, VIVO, EGY, STCNAugust 23, 2022 | markets.businessinsider.comMeridian Bioscience, Inc. (NASDAQ:VIVO) Sees Large Increase in Short InterestMeridian Bioscience, Inc. (NASDAQ:VIVO - Get Rating) saw a significant growth in short interest during the month of July. As of July 31st, there was short interest totalling 3,360,000 shares, a growth of 18.7% from the July 15th total of 2,830,000 shares. Based on an average daily volume of 779,100 shares, the short-interest ratio is currently 4.3 days. Approximately 7.8% of the shares of the stock are sold short.August 13, 2022 | marketbeat.comStockNews.com Lowers Meridian Bioscience (NASDAQ:VIVO) to HoldStockNews.com lowered Meridian Bioscience from a "buy" rating to a "hold" rating in a research report on Tuesday.August 9, 2022 | marketbeat.comMeridian Bioscience (VIVO) Meets Q3 Earnings EstimatesAugust 5, 2022 | finance.yahoo.com Get Meridian Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for VIVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Sell NVDA Now? (Ad)Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%. Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). VIVO Media Mentions By Week VIVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VIVO News Sentiment▼0.000.43▲Average Medical News Sentiment VIVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VIVO Articles This Week▼00▲VIVO Articles Average Week Get Meridian Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for VIVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RIOT News Today MMSI News Today XRAY News Today ICUI News Today HAE News Today NEOG News Today QDEL News Today STAA News Today ANIK News Today OSUR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VIVO) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Meridian Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Meridian Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
